Detalhe da pesquisa
1.
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.
J Hepatol
; 62(6): 1237-45, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25559326
2.
GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees.
Gastroenterology
; 144(7): 1508-17, 1517.e1-10, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23415804
3.
Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel Toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses.
J Pharmacol Exp Ther
; 348(1): 96-105, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24133297
4.
Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
J Pharmacol Toxicol Methods
; 60(1): 58-68, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19426820